Saint Barthélemy

Reimbursed Care Access

Saint Barthélemy is an overseas collectivity of France and, except where local adaptations apply, French national drug and health laws govern controlled substances and medical reimbursement there. Esketamine (SPRAVATO) is available in France under restricted hospital pathways with a narrowly defined reimbursement decision; ketamine is an authorized anesthetic and used off‑label in psychiatry but without broad public reimbursement for psychiatric indications. Most classic psychedelics (psilocybin, MDMA, DMT, mescaline, ayahuasca, ibogaine, 2C‑X, etc.) are listed as stupéfiants under French law and have no authorized outpatient medical reimbursement outside approved clinical research.